Sign in
4

Changes in Ownership

KALA BIO, Inc. Filed Acc 0001179110-20-000157

Options or other derivatives

  • Chief Scientific Officer acquired 120,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Chen Hongming · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-01-02 Grant or award : show line 1 in the form Stock Option (right to buy) +120,000 $3.84 2030-01-01 120,000 120,000 D
Loading xslF345X03/edgar.xml…